| Paul A Rushing, MD | |
|
1455 E Bert Kouns Loop, Shreveport, LA 71105-5634 | |
| (318) 798-4488 | |
| (318) 798-4420 |
| Full Name | Paul A Rushing |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 1455 E Bert Kouns Loop, Shreveport, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003810904 | NPI | - | NPPES |
| 1696781 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 12187R (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stat Home Health Of Northwest Louisiana, Llc | Sibley, LA | Home health agency |
| Louisiana Homecare | Mansfield, LA | Home health agency |
| Christus Homecare Schumpert | Shreveport, LA | Home health agency |
| Christus Health Shreveport - Bossier | Shreveport, LA | Hospital |
| Willis Knighton Medical Center, Inc | Shreveport, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Highland Clinic, A Prof Med Corp | 3870493463 | 49 |
News Archive
Intellect Neurosciences, Inc announced it has received a Notice of Allowance from the Israeli Patent and Trademark Office for a new patent related to the Company's clinical-stage drug candidate OX1 (OXIGON), which has disease-modifying potential for Alzheimer's and other neurodegenerative disorders.
As little as 20 minutes of moderate exercise three times per week during pregnancy enhances the newborn child's brain development, according to researchers at the University of Montreal and its affiliated CHU Sainte-Justine children's hospital.
Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study.
A new study reports the results of molecular dynamic simulations that were performed in an effort to identify new drugs that could be effective against SARS-CoV-2.
› Verified 1 days ago
| Entity Name | Highland Clinic, A Prof Med Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053315846 PECOS PAC ID: 3870493463 Enrollment ID: O20040220000551 |
News Archive
Intellect Neurosciences, Inc announced it has received a Notice of Allowance from the Israeli Patent and Trademark Office for a new patent related to the Company's clinical-stage drug candidate OX1 (OXIGON), which has disease-modifying potential for Alzheimer's and other neurodegenerative disorders.
As little as 20 minutes of moderate exercise three times per week during pregnancy enhances the newborn child's brain development, according to researchers at the University of Montreal and its affiliated CHU Sainte-Justine children's hospital.
Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study.
A new study reports the results of molecular dynamic simulations that were performed in an effort to identify new drugs that could be effective against SARS-CoV-2.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul A Rushing, MD 1455 E Bert Kouns Loop, Shreveport, LA 71105-5634 Ph: (318) 798-4488 | Paul A Rushing, MD 1455 E Bert Kouns Loop, Shreveport, LA 71105-5634 Ph: (318) 798-4488 |
News Archive
Intellect Neurosciences, Inc announced it has received a Notice of Allowance from the Israeli Patent and Trademark Office for a new patent related to the Company's clinical-stage drug candidate OX1 (OXIGON), which has disease-modifying potential for Alzheimer's and other neurodegenerative disorders.
As little as 20 minutes of moderate exercise three times per week during pregnancy enhances the newborn child's brain development, according to researchers at the University of Montreal and its affiliated CHU Sainte-Justine children's hospital.
Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study.
A new study reports the results of molecular dynamic simulations that were performed in an effort to identify new drugs that could be effective against SARS-CoV-2.
› Verified 1 days ago
Mansi Shah, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1455 E Bert Koun Loop, #210, Shreveport, LA 71105 Phone: 318-798-4515 Fax: 318-798-4530 | |
Pratik Agrawal, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Dr. Bader Alotaibi, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2727 Hearne Ave Ste 301, Shreveport, LA 71103 Phone: 318-631-6400 | |
Sanjay Jain, Internal Medicine Medicare: Medicare Enrolled Practice Location: 510 E Stoner Ave, Primary Care (110), Shreveport, LA 71101 Phone: 318-221-8411 | |
Steven R Bailey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 | |
Venkateswara K Rao, M.D., Internal Medicine Medicare: Medicare Enrolled Practice Location: 1501 Kings Hwy, Department Of Medicine, Shreveport, LA 71103 Phone: 318-675-5000 |